BTD and thyroid cancer: Cytoplasmic expression of biotinidase was observed in 6/23 (26.1%) benign cases as compared to 2/20 (10%) in thyroid cancer cases (p = 0.25, OR = 0.315, 95% C.I. = 0.056−1.78).